Results 191 to 200 of about 4,104,345 (353)

Remote Monitoring of Patients with Heart Failure: Characteristics of Effective Programs and Implementation Strategies

open access: yesVascular Health and Risk Management
Ioana Camelia Teleanu,1 Gabriel Cristian Bejan,1 Ioana Ruxandra Poiană,1 Anca Mîrșu-Păun,1 Silviu Ionel Dumitrescu,2,3 Ana Maria Alexandra Stănescu1,2,4,5 1“Carol Davila” University of Medicine and Pharmacy, Bucharest ...
Teleanu IC   +5 more
doaj  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Assessment of medical device features in health technology assessment: a review of NICE medical technology guidance. [PDF]

open access: yesInt J Technol Assess Health Care
Pearson S   +5 more
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Apple Vision Pro: A Paradigm Shift in Medical Technology. [PDF]

open access: yesCureus
Shanbhag NM   +3 more
europepmc   +1 more source

Visualization technology in medical education [PDF]

open access: hybrid, 1999
Faao Sherman Gorbis, Richard C. Hallgren
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy